ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 49 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $825 | -15.7% | 1,058 | 0.0% | 0.00% | – |
| Q2 2023 | $979 | -94.6% | 1,058 | -93.4% | 0.00% | – |
| Q3 2022 | $18,000 | +800.0% | 16,049 | +1345.9% | 0.00% | – |
| Q2 2022 | $2,000 | -90.9% | 1,110 | -89.4% | 0.00% | – |
| Q1 2022 | $22,000 | +29.4% | 10,477 | +135.5% | 0.00% | – |
| Q4 2021 | $17,000 | -41.4% | 4,449 | -22.3% | 0.00% | – |
| Q3 2021 | $29,000 | +480.0% | 5,729 | +403.0% | 0.00% | – |
| Q2 2021 | $5,000 | -28.6% | 1,139 | -14.2% | 0.00% | – |
| Q1 2021 | $7,000 | 0.0% | 1,327 | -7.6% | 0.00% | – |
| Q4 2020 | $7,000 | -53.3% | 1,436 | -24.7% | 0.00% | – |
| Q3 2020 | $15,000 | +7.1% | 1,907 | +40.4% | 0.00% | – |
| Q2 2020 | $14,000 | +180.0% | 1,358 | -31.2% | 0.00% | – |
| Q1 2020 | $5,000 | – | 1,973 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 12,025,999 | $66,263,000 | 2.30% |
| Abingworth LLP | 250,000 | $1,375,000 | 1.02% |
| Tekla Capital Management LLC | 1,466,368 | $8,080,000 | 0.31% |
| Rock Springs Capital Management LP | 875,000 | $4,821,000 | 0.28% |
| QVT Financial LP | 1,360,647 | $6,940,000 | 0.22% |
| Vident Investment Advisory, LLC | 232,641 | $1,282,000 | 0.13% |
| Hillhouse Capital Management | 1,190,476 | $6,560,000 | 0.13% |
| Orbimed Advisors | 1,914,660 | $10,550,000 | 0.12% |
| Granite Investment Partners, LLC | 195,571 | $1,078,000 | 0.07% |
| Monashee Investment Management LLC | 25,000 | $138,000 | 0.06% |